EVALUATION OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY. Int. Res. J. Pharm. 2024;15(6):35-39. Accessed June 1, 2026. https://irjponline.org/index.php/irjp/article/view/92